MarketCap
Facebook
X
TelegramQuartalsbericht 2026-Q3
hinzugefügt 14.05.2026
Pluristem Therapeutics ROE 2011-2026 | PSTI
ROE Jährlich Pluristem Therapeutics
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -339.81 | 22233.33 | 216.3 | -137.29 | -87.25 | -51.96 | -161.8 | -91.65 | -91.94 | -60.92 | -42.44 | -43.35 | -36.81 | -39.2 | -24.98 | -70.86 | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 22233.33 | -339.81 | 1323.08 |
ROE Vierteljährlich Pluristem Therapeutics
| 2026-Q3 | 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 170.9 | 192.57 | 285.18 | 335.02 | 9626.74 | 9575.24 | 9288.36 | 9076.83 | 8930.55 | -405.96 | -445.95 | -191.58 | -140.2 | -95.26 | -142.66 | -127.24 | -122.19 | -122.81 | -114.55 | -114.92 | -117.97 | -111.94 | -103.3 | -95.7 | -105.23 | -132.76 | -142.29 | -165.68 | -182.79 | -195.74 | -160.31 | -141.84 | -115.01 | -57.18 | -79.45 | -105.15 | -109.21 | -98.12 | -102.17 | -91.08 | -72.79 | -64.79 | -46.5 | -38.51 | -43.19 | -42.97 | -47.65 | -47.44 | -45.75 | -43.42 | -41.73 | -39.4 | -34.88 | -31.74 | -27.22 | -29.13 | -27.56 | -33.18 | -31.61 | -32.17 | -11.15 | -4.94 | -11.15 |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 9626.74 | -445.95 | 669.78 |
ROE anderer Aktien in der Pharmaeinzelhändler
| Name | ROE | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
FSD Pharma
HUGE
|
-528.29 | - | 5743.5 % | $ 69.7 M |  Canada |
 |
MorphoSys AG
MOR
|
15.76 | - | 2.43 % | $ 254 M |  Germany |
 |
Happiness Biotech Group Limited
HAPP
|
-32.54 | - | 1.35 % | $ 17.8 M |  China |
 |
AgeX Therapeutics
AGE
|
51843.24 | - | -10.17 % | $ 12.2 K |  USA |
 |
Coherus BioSciences
CHRS
|
275.39 | $ 1.66 | 1.22 % | $ 194 M | USA |
 |
I-Mab
IMAB
|
-85.31 | - | - | $ 866 M | China |
 |
Celldex Therapeutics
CLDX
|
-49.08 | $ 31.65 | 2.59 % | $ 2.1 B | USA |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
5.18 | - | - | $ 40.3 B | USA |
 |
Biophytis SA
BPTS
|
-751.94 | - | -13.47 % | $ 169 M |  France |
 |
Genfit SA
GNFT
|
626.29 | - | 2.54 % | $ 160 B | France |
 |
BioNTech SE
BNTX
|
-5.91 | $ 93.0 | 0.81 % | $ 22.5 B | Germany |
 |
CRISPR Therapeutics AG
CRSP
|
-30.26 | $ 53.53 | 3.76 % | $ 4.81 B |  Schweiz |
 |
AstraZeneca PLC
AZN
|
21.0 | - | - | $ 96.9 B |  Britain |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
-115.61 | - | -1.52 % | $ 24.7 M | USA |
 |
Athira Pharma
ATHA
|
-380.03 | - | - | $ 269 M | USA |
 |
BiondVax Pharmaceuticals Ltd.
BVXV
|
30.52 | - | 0.74 % | $ 768 M |  Israel |
 |
Compugen Ltd.
CGEN
|
34.4 | $ 2.76 | 4.15 % | $ 258 M | Israel |
 |
Abcam plc
ABCM
|
-1.17 | - | - | $ 4.9 B | Britain |
 |
Galera Therapeutics
GRTX
|
3750.6 | - | -32.59 % | $ 7.61 M | USA |
 |
Midatech Pharma plc
MTP
|
-55.98 | - | -18.52 % | $ 27.3 M | Britain |
|
Enlivex Therapeutics Ltd.
ENLV
|
63.85 | $ 0.78 | 14.33 % | $ 35.6 M | Israel |
 |
Esperion Therapeutics
ESPR
|
7.51 | $ 3.13 | 0.32 % | $ 651 M | USA |
 |
Eton Pharmaceuticals
ETON
|
-17.59 | $ 32.4 | 3.55 % | $ 872 M | USA |
 |
Affimed N.V.
AFMD
|
-183.26 | - | -34.95 % | $ 21.5 M | Germany |
|
Forte Biosciences
FBRX
|
-113.75 | $ 21.47 | -2.14 % | $ 278 M | USA |
 |
Институт стволовых клеток человека
ISKJ
|
17.55 | - | - | - |  Russia |
 |
Checkmate Pharmaceuticals
CMPI
|
-88.4 | - | - | $ 231 M | USA |
 |
Celyad Oncology SA
CYAD
|
-948.23 | - | - | $ 12.5 M |  Belgium |
 |
Berkeley Lights
BLI
|
-69.02 | - | -7.31 % | $ 87 M | USA |
 |
Galectin Therapeutics
GALT
|
24.11 | $ 2.7 | -3.23 % | $ 173 M | USA |
 |
Generation Bio Co.
GBIO
|
-152.74 | - | - | $ 344 M | USA |
 |
IMV
IMV
|
575.45 | - | - | $ 13.1 M | Canada |
 |
Akero Therapeutics
AKRO
|
-33.6 | - | - | $ 3.67 B | USA |
 |
Akouos
AKUS
|
-37.09 | - | 0.23 % | $ 488 M | USA |
 |
Grifols, S.A.
GRFS
|
2.47 | $ 8.05 | 0.5 % | $ 5.47 B |  Spain |
 |
Ayala Pharmaceuticals
AYLA
|
3458.87 | - | - | $ 7.46 M | Israel |
 |
Hutchison China MediTech Limited
HCM
|
36.91 | $ 11.72 | -0.26 % | $ 10.1 B | China |
 |
Heron Therapeutics
HRTX
|
-139.54 | $ 0.91 | 3.0 % | $ 152 M | USA |
 |
ImmuCell Corporation
ICCC
|
-3.84 | $ 10.63 | 1.24 % | $ 95.9 M | USA |
 |
Cyclacel Pharmaceuticals
CYCCP
|
43.82 | - | -4.36 % | $ 27 M | USA |
 |
Freeline Therapeutics Holdings plc
FRLN
|
-169.75 | - | - | $ 384 M | Britain |
 |
Gracell Biotechnologies
GRCL
|
-44.16 | - | - | $ 3.37 B | China |
 |
Anika Therapeutics
ANIK
|
-7.58 | $ 14.81 | -0.54 % | $ 212 M | USA |
 |
Advaxis
ADXS
|
196.88 | - | -9.65 % | $ 45.9 M | USA |
 |
Aeterna Zentaris
AEZS
|
-401.79 | - | 5.93 % | $ 314 M | Canada |
 |
Ionis Pharmaceuticals
IONS
|
-46.9 | $ 76.49 | 0.55 % | $ 12.2 B | USA |
 |
Aeglea BioTherapeutics
AGLE
|
-21.7 | - | - | $ 1.01 B | USA |
 |
CureVac N.V.
CVAC
|
-59.8 | - | - | $ 867 M | Germany |
 |
Applied Genetic Technologies Corporation
AGTC
|
-62.37 | - | - | $ 26.5 M | USA |
 |
AIkido Pharma
AIKI
|
-32.34 | - | 1.93 % | $ 17.4 M | USA |